Citationbioscience

Citation Bioscience sells hemp-derived cannabinoid finished goods and bulk ingredients: tinctures, softgels, topicals, gummies, isolates and distillates priced mid-range to premium. All formulas are THC-compliant (<0.3 %) and come with third-party COAs. Products are sold business-to-business through the company website and by direct sales to brands, contract manufacturers and compounding pharmacies; no consumer retail storefronts are operated. The company positions itself as a science-first, cGMP-certified supplier that controls the pipeline from USDA-organic Colorado hemp to finished packaged goods. It offers white-label, private-label and custom-formulation services with low 250-unit MOQs and can deliver in 2–4 weeks from Colorado and California facilities. Notable SKUs include water-soluble nano-CBD tinctures, CBG/CBD 1:1 softgels and THC-free broad-spectrum distillate for national pharmacy chains. Buyers are small-to-mid-size wellness brands, functional-beverage startups, dermatology clinics and independent pharmacies that need compliant, documented inputs but lack in-house extraction or regulatory teams. They value U.S.-grown biomass, validated potency data and marketing-ready packaging rather than commodity isolate. Citation competes with large hemp extractors and turnkey white-label mills by combining analytical rigor—every lot is tested for cannabinoids, pesticides, microbials and heavy metals—with boutique customer service and flexible batch sizes. Its cGMP, ISO-9001 and soon-to-be NSF-certified facilities let customers enter retail or pharmacy channels that cheaper, non-validated competitors cannot service.